COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

CRQ Survey Study: Clinical Research Questionnaire of Oncology Patients - A Nationwide Survey

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02836392
Recruitment Status : Completed
First Posted : July 19, 2016
Last Update Posted : August 10, 2017
Sponsor:
Information provided by (Responsible Party):
Cancer Trials Ireland

Brief Summary:
This is a translational, multicentre questionnaire study. The study design follows that of a cross sectional, quantitative research approach. Data collection will involve self-administered, paper-based questionnaires. The method of data collection allows for a large sample size without major expense. The questionnaires are comprised of several questions examining areas such as demographic details, cancer diagnosis, understanding of the term 'clinical trials', attitudes to personal participation in cancer clinical research and the experience of patients who previously participated in a cancer clinical trial. The study will be opened in all interested hospitals in Ireland following initiation of the study at each site. Questionnaire completion will be seen as implied informed consent and no formal consent will need to be signed by the patient. The paper-based questionnaire responses will be electronically and anonymously recorded in a computer database to facilitate analysis.

Condition or disease Intervention/treatment
Cancer Behavioral: Questionnaire

Layout table for study information
Study Type : Observational
Actual Enrollment : 1000 participants
Observational Model: Case-Only
Time Perspective: Prospective
Study Start Date : May 2016
Actual Primary Completion Date : December 2016
Actual Study Completion Date : January 2017



Primary Outcome Measures :
  1. Oncology patients' understanding of the term 'clinical trials' and their attitudes towards personal participation in cancer clinical research will be evaluated by questionnaire. [ Time Frame: 1 year ]

Secondary Outcome Measures :
  1. The patient related factors, including level of education and socioeconomic status that influence their decision regarding participation in a cancer clinical trial (CCT) will be explored by questionnaire. [ Time Frame: 1 year ]
  2. The patients' experience surrounding the discussion regarding CCT participation and their actual experience when enrolled in a CCT will be investigated by questionnaire. [ Time Frame: 1 year ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
This is a translational, multicentre questionnaire study.
Criteria

Inclusion Criteria:

  • Clinical diagnosis of malignancy
  • Aged 18 years or older
  • Ability to complete the questionnaire or independently or with the help of a friend, relative, or staff member of the oncology department

Exclusion Criteria:

  • N/A

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02836392


Locations
Layout table for location information
Ireland
University Hospital Waterford
Waterford, Co Waterford, Ireland
AMNCH
Tallaght, Dublin 24, Ireland
St Vincent's University Hospital
Elm Park, Dublin 4, Ireland
Beaumont Hospital
Beaumont Road, Dublin, Ireland, 9
Bon Secours Hospital
Cork, Ireland
Cork University Hospital
Cork, Ireland
Saint Luke's Hospital Rathgar
Dublin, Ireland, 6
Beacon Hospital
Dublin, Ireland
Mater Misericordiae University Hospital
Dublin, Ireland
St James Hospital
Dublin, Ireland
University Hospital Galway
Galway, Ireland
Letterkenny General Hospital
Letterkenny, Ireland
University Hospital Limerick
Limerick, Ireland
Sligo University Hospital
Sligo, Ireland
Sponsors and Collaborators
Cancer Trials Ireland
Layout table for additonal information
Responsible Party: Cancer Trials Ireland
ClinicalTrials.gov Identifier: NCT02836392    
Other Study ID Numbers: ICORG 15-43
First Posted: July 19, 2016    Key Record Dates
Last Update Posted: August 10, 2017
Last Verified: August 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes